ArticleJournal of cellular and molecular medicine2024
MSA-MaxNet: Multi-Scale Attention Enhanced Multi-Axis Vision Transformer Network for Medical Image Segmentation.
Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- VTC-Net: A Semantic Segmentation Network for Ore Particles Integrating Transformer and Convolutional Block Attention Module (CBAM).Sensors (Basel, Switzerland) · 2026Article
- eCBT-I dialogue system: a comparative evaluation of large language models and adaptation strategies for insomnia treatment.Journal of translational medicine · 2025Article
- E-SegNet: E-Shaped Structure Networks for Accurate 2D and 3D Medical Image Segmentation.Research (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Convolutional neural networks (CNNs) are well established in handling local features in visual tasks; yet, they falter in managing complex spatial relationships and long-range dependencies that are crucial for medical image segmentation, particularly in identifying pathological changes. While vision transformer (ViT) excels in addressing long-range dependencies, their ability to leverage local features remains inadequate. Recent ViT variants have merged CNNs to improve feature representation and segmentation outcomes, yet challenges with limited receptive fields and precise feature representation persist. In this work, we propose MSA-MaxNet. Specifically, our model utilises an encoder-decoder structure, using MaxViT blocks that apply multi-axis self-attention (Max-SA) as the encoder for local and global feature extraction. To restore the feature map's spatial resolution during upsampling operations, a symmetric MaxViT block-based decoder and upsampling layers are employed. To address the feature mismatches in the skip connections of UNet architecture, we introduce convolutional block attention module (CBAM). Furthermore, we design a multi-scale convolutional block attention module (MCBAM) based on CBAM, which utilises multi-scale features to enhance feature representation and refine the skip connection. We evaluate the segmentation performance of MSA-MaxNet on three publicly available medical imaging datasets, including Synapse for multi-organ segmentation, ACDC for cardiac analysis and Kvasir-SEG for gastrointestinal polyp detection. Notably, MSA-MaxNet achieves state-of-the-art (SOTA) Dice scores of 85.59% and 95.26% on Synapse and Kvasir-SEG datasets, respectively, with 40.28 M parameters. Additionally, we introduce two smaller versions of MSA-MaxNet to meet the demands of various scenarios. In summary, our work provides a robust framework for diverse medical imaging tasks, offering potential applications in early cancer detection, cardiovascular disease diagnosis and comprehensive organ-level assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.